nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—CYP11A1—type 2 diabetes mellitus	0.232	0.732	CbGaD
Dinoprostone—CYP1A2—type 2 diabetes mellitus	0.0851	0.268	CbGaD
Dinoprostone—SLCO2B1—Tolbutamide—type 2 diabetes mellitus	0.0499	0.121	CbGbCtD
Dinoprostone—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0324	0.0784	CbGbCtD
Dinoprostone—SLCO1B1—Repaglinide—type 2 diabetes mellitus	0.032	0.0774	CbGbCtD
Dinoprostone—SLCO1B1—Pioglitazone—type 2 diabetes mellitus	0.029	0.07	CbGbCtD
Dinoprostone—SLCO2B1—Glyburide—type 2 diabetes mellitus	0.0287	0.0693	CbGbCtD
Dinoprostone—SLCO1A2—Tolbutamide—type 2 diabetes mellitus	0.0274	0.0661	CbGbCtD
Dinoprostone—SLCO1B1—Rosiglitazone—type 2 diabetes mellitus	0.0267	0.0646	CbGbCtD
Dinoprostone—SLCO1B1—Valsartan—type 2 diabetes mellitus	0.0236	0.0571	CbGbCtD
Dinoprostone—SLC22A7—Glyburide—type 2 diabetes mellitus	0.0224	0.0542	CbGbCtD
Dinoprostone—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.0186	0.045	CbGbCtD
Dinoprostone—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0166	0.0401	CbGbCtD
Dinoprostone—SLCO1A2—Glyburide—type 2 diabetes mellitus	0.0157	0.038	CbGbCtD
Dinoprostone—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0141	0.0341	CbGbCtD
Dinoprostone—SLCO1B1—Losartan—type 2 diabetes mellitus	0.0136	0.0328	CbGbCtD
Dinoprostone—SLC22A2—Metformin—type 2 diabetes mellitus	0.00967	0.0234	CbGbCtD
Dinoprostone—SLC22A6—Glyburide—type 2 diabetes mellitus	0.00953	0.023	CbGbCtD
Dinoprostone—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00876	0.0212	CbGbCtD
Dinoprostone—SLC22A6—Losartan—type 2 diabetes mellitus	0.00872	0.0211	CbGbCtD
Dinoprostone—SLC22A1—Metformin—type 2 diabetes mellitus	0.0084	0.0203	CbGbCtD
Dinoprostone—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00689	0.0167	CbGbCtD
Dinoprostone—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00652	0.0158	CbGbCtD
Dinoprostone—CYP1A2—Losartan—type 2 diabetes mellitus	0.00444	0.0107	CbGbCtD
Dinoprostone—PTGIR—artery—type 2 diabetes mellitus	0.00163	0.0358	CbGeAlD
Dinoprostone—PTGIR—endothelium—type 2 diabetes mellitus	0.00138	0.0302	CbGeAlD
Dinoprostone—SLC51B—cortex of kidney—type 2 diabetes mellitus	0.00124	0.0272	CbGeAlD
Dinoprostone—PTGER4—cardiovascular system—type 2 diabetes mellitus	0.00095	0.0208	CbGeAlD
Dinoprostone—PTGER4—kidney—type 2 diabetes mellitus	0.00093	0.0204	CbGeAlD
Dinoprostone—PTGER4—cortex of kidney—type 2 diabetes mellitus	0.000906	0.0199	CbGeAlD
Dinoprostone—PTGER1—kidney—type 2 diabetes mellitus	0.000898	0.0197	CbGeAlD
Dinoprostone—PTGER1—pancreas—type 2 diabetes mellitus	0.000892	0.0196	CbGeAlD
Dinoprostone—SLC51A—cortex of kidney—type 2 diabetes mellitus	0.00089	0.0195	CbGeAlD
Dinoprostone—PTGER2—adipose tissue—type 2 diabetes mellitus	0.000854	0.0187	CbGeAlD
Dinoprostone—PTGER4—adipose tissue—type 2 diabetes mellitus	0.000838	0.0184	CbGeAlD
Dinoprostone—SLC51B—liver—type 2 diabetes mellitus	0.000806	0.0177	CbGeAlD
Dinoprostone—PTGER3—kidney—type 2 diabetes mellitus	0.000788	0.0173	CbGeAlD
Dinoprostone—PTGER3—adipose tissue—type 2 diabetes mellitus	0.00071	0.0156	CbGeAlD
Dinoprostone—HPGDS—cardiovascular system—type 2 diabetes mellitus	0.000696	0.0153	CbGeAlD
Dinoprostone—SLCO2A1—islet of Langerhans—type 2 diabetes mellitus	0.000685	0.015	CbGeAlD
Dinoprostone—HPGDS—kidney—type 2 diabetes mellitus	0.000681	0.0149	CbGeAlD
Dinoprostone—HPGDS—pancreas—type 2 diabetes mellitus	0.000676	0.0148	CbGeAlD
Dinoprostone—SLCO4A1—islet of Langerhans—type 2 diabetes mellitus	0.000631	0.0138	CbGeAlD
Dinoprostone—SLC22A11—nephron tubule—type 2 diabetes mellitus	0.000615	0.0135	CbGeAlD
Dinoprostone—HPGDS—adipose tissue—type 2 diabetes mellitus	0.000613	0.0134	CbGeAlD
Dinoprostone—SLCO3A1—retina—type 2 diabetes mellitus	0.000592	0.013	CbGeAlD
Dinoprostone—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00058	0.0127	CbGeAlD
Dinoprostone—SLC51A—liver—type 2 diabetes mellitus	0.000577	0.0127	CbGeAlD
Dinoprostone—PTGFR—adipose tissue—type 2 diabetes mellitus	0.000567	0.0124	CbGeAlD
Dinoprostone—PTGIR—cardiovascular system—type 2 diabetes mellitus	0.000567	0.0124	CbGeAlD
Dinoprostone—SLCO1C1—kidney—type 2 diabetes mellitus	0.000557	0.0122	CbGeAlD
Dinoprostone—PTGIR—kidney—type 2 diabetes mellitus	0.000555	0.0122	CbGeAlD
Dinoprostone—SLCO2A1—nephron tubule—type 2 diabetes mellitus	0.000552	0.0121	CbGeAlD
Dinoprostone—PTGIR—pancreas—type 2 diabetes mellitus	0.000551	0.0121	CbGeAlD
Dinoprostone—SLC22A11—kidney—type 2 diabetes mellitus	0.000541	0.0119	CbGeAlD
Dinoprostone—SLCO4A1—retina—type 2 diabetes mellitus	0.000539	0.0118	CbGeAlD
Dinoprostone—ABCC5—retina—type 2 diabetes mellitus	0.000536	0.0118	CbGeAlD
Dinoprostone—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000535	0.0117	CbGeAlD
Dinoprostone—SLC22A7—kidney—type 2 diabetes mellitus	0.000528	0.0116	CbGeAlD
Dinoprostone—SLC22A11—cortex of kidney—type 2 diabetes mellitus	0.000527	0.0115	CbGeAlD
Dinoprostone—SLC22A7—cortex of kidney—type 2 diabetes mellitus	0.000514	0.0113	CbGeAlD
Dinoprostone—SLCO4A1—nephron tubule—type 2 diabetes mellitus	0.000508	0.0111	CbGeAlD
Dinoprostone—ABCC5—nephron tubule—type 2 diabetes mellitus	0.000505	0.0111	CbGeAlD
Dinoprostone—SLCO1C1—adipose tissue—type 2 diabetes mellitus	0.000502	0.011	CbGeAlD
Dinoprostone—PTGIR—adipose tissue—type 2 diabetes mellitus	0.0005	0.011	CbGeAlD
Dinoprostone—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.000496	0.0109	CbGeAlD
Dinoprostone—SLCO3A1—kidney—type 2 diabetes mellitus	0.00049	0.0107	CbGeAlD
Dinoprostone—SLCO2A1—kidney—type 2 diabetes mellitus	0.000485	0.0106	CbGeAlD
Dinoprostone—SLCO2A1—pancreas—type 2 diabetes mellitus	0.000482	0.0106	CbGeAlD
Dinoprostone—SLCO3A1—cortex of kidney—type 2 diabetes mellitus	0.000477	0.0105	CbGeAlD
Dinoprostone—SLCO2A1—cortex of kidney—type 2 diabetes mellitus	0.000472	0.0104	CbGeAlD
Dinoprostone—SLC22A2—kidney—type 2 diabetes mellitus	0.00047	0.0103	CbGeAlD
Dinoprostone—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000457	0.01	CbGeAlD
Dinoprostone—SLCO4A1—kidney—type 2 diabetes mellitus	0.000446	0.00978	CbGeAlD
Dinoprostone—SLCO4A1—pancreas—type 2 diabetes mellitus	0.000443	0.00972	CbGeAlD
Dinoprostone—SLCO3A1—adipose tissue—type 2 diabetes mellitus	0.000441	0.00968	CbGeAlD
Dinoprostone—SLCO2A1—adipose tissue—type 2 diabetes mellitus	0.000437	0.00958	CbGeAlD
Dinoprostone—SLCO4A1—cortex of kidney—type 2 diabetes mellitus	0.000435	0.00953	CbGeAlD
Dinoprostone—CYP11A1—adipose tissue—type 2 diabetes mellitus	0.000433	0.00948	CbGeAlD
Dinoprostone—HPGDS—liver—type 2 diabetes mellitus	0.00043	0.00943	CbGeAlD
Dinoprostone—SLCO4A1—adipose tissue—type 2 diabetes mellitus	0.000402	0.00882	CbGeAlD
Dinoprostone—ABCC5—adipose tissue—type 2 diabetes mellitus	0.0004	0.00876	CbGeAlD
Dinoprostone—PTGFR—liver—type 2 diabetes mellitus	0.000398	0.00872	CbGeAlD
Dinoprostone—SLCO1B1—kidney—type 2 diabetes mellitus	0.000393	0.00861	CbGeAlD
Dinoprostone—PTGIR—liver—type 2 diabetes mellitus	0.000351	0.00769	CbGeAlD
Dinoprostone—ABCC4—nephron tubule—type 2 diabetes mellitus	0.00035	0.00767	CbGeAlD
Dinoprostone—SLCO2B1—kidney—type 2 diabetes mellitus	0.000347	0.00761	CbGeAlD
Dinoprostone—SLC22A8—nephron tubule—type 2 diabetes mellitus	0.000347	0.00761	CbGeAlD
Dinoprostone—SLC22A11—liver—type 2 diabetes mellitus	0.000342	0.00749	CbGeAlD
Dinoprostone—SLC22A7—liver—type 2 diabetes mellitus	0.000334	0.00731	CbGeAlD
Dinoprostone—SLC22A1—kidney—type 2 diabetes mellitus	0.000332	0.00727	CbGeAlD
Dinoprostone—SLCO1A2—kidney—type 2 diabetes mellitus	0.000319	0.007	CbGeAlD
Dinoprostone—SLCO2B1—adipose tissue—type 2 diabetes mellitus	0.000313	0.00686	CbGeAlD
Dinoprostone—SLCO3A1—liver—type 2 diabetes mellitus	0.00031	0.00679	CbGeAlD
Dinoprostone—ABCC4—kidney—type 2 diabetes mellitus	0.000307	0.00674	CbGeAlD
Dinoprostone—SLCO2A1—liver—type 2 diabetes mellitus	0.000307	0.00672	CbGeAlD
Dinoprostone—ABCC4—pancreas—type 2 diabetes mellitus	0.000305	0.0067	CbGeAlD
Dinoprostone—SLC22A8—kidney—type 2 diabetes mellitus	0.000305	0.00669	CbGeAlD
Dinoprostone—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000299	0.00657	CbGeAlD
Dinoprostone—SLC22A1—adipose tissue—type 2 diabetes mellitus	0.000299	0.00656	CbGeAlD
Dinoprostone—SLC22A8—cortex of kidney—type 2 diabetes mellitus	0.000297	0.00651	CbGeAlD
Dinoprostone—SLCO4A1—liver—type 2 diabetes mellitus	0.000282	0.00618	CbGeAlD
Dinoprostone—CYP19A1—adipose tissue—type 2 diabetes mellitus	0.000281	0.00616	CbGeAlD
Dinoprostone—ABCC5—liver—type 2 diabetes mellitus	0.00028	0.00615	CbGeAlD
Dinoprostone—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000277	0.00608	CbGeAlD
Dinoprostone—SLCO1B1—liver—type 2 diabetes mellitus	0.000248	0.00544	CbGeAlD
Dinoprostone—SLCO2B1—liver—type 2 diabetes mellitus	0.000219	0.00481	CbGeAlD
Dinoprostone—SLC22A1—liver—type 2 diabetes mellitus	0.00021	0.0046	CbGeAlD
Dinoprostone—SLCO1A2—liver—type 2 diabetes mellitus	0.000202	0.00443	CbGeAlD
Dinoprostone—CYP19A1—liver—type 2 diabetes mellitus	0.000197	0.00432	CbGeAlD
Dinoprostone—ABCC4—liver—type 2 diabetes mellitus	0.000194	0.00426	CbGeAlD
Dinoprostone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000165	0.00164	CcSEcCtD
Dinoprostone—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000164	0.00164	CcSEcCtD
Dinoprostone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000164	0.00163	CcSEcCtD
Dinoprostone—Flushing—Irbesartan—type 2 diabetes mellitus	0.000163	0.00163	CcSEcCtD
Dinoprostone—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000162	0.00161	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000161	0.0016	CcSEcCtD
Dinoprostone—Syncope—Valsartan—type 2 diabetes mellitus	0.00016	0.00159	CcSEcCtD
Dinoprostone—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00016	0.00159	CcSEcCtD
Dinoprostone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000159	0.00158	CcSEcCtD
Dinoprostone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000158	0.00158	CcSEcCtD
Dinoprostone—Chills—Irbesartan—type 2 diabetes mellitus	0.000158	0.00157	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00157	CcSEcCtD
Dinoprostone—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000158	0.00157	CcSEcCtD
Dinoprostone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000158	0.00157	CcSEcCtD
Dinoprostone—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000157	0.00156	CcSEcCtD
Dinoprostone—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000157	0.00156	CcSEcCtD
Dinoprostone—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000157	0.00156	CcSEcCtD
Dinoprostone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000157	0.00156	CcSEcCtD
Dinoprostone—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000157	0.00156	CcSEcCtD
Dinoprostone—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000156	0.00155	CcSEcCtD
Dinoprostone—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000156	0.00155	CcSEcCtD
Dinoprostone—Cough—Valsartan—type 2 diabetes mellitus	0.000156	0.00155	CcSEcCtD
Dinoprostone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000156	0.00155	CcSEcCtD
Dinoprostone—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000155	0.00154	CcSEcCtD
Dinoprostone—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000155	0.00154	CcSEcCtD
Dinoprostone—Cough—Orlistat—type 2 diabetes mellitus	0.000154	0.00153	CcSEcCtD
Dinoprostone—Flushing—Losartan—type 2 diabetes mellitus	0.000154	0.00153	CcSEcCtD
Dinoprostone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000154	0.00153	CcSEcCtD
Dinoprostone—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000153	0.00152	CcSEcCtD
Dinoprostone—Vision blurred—Metformin—type 2 diabetes mellitus	0.000153	0.00152	CcSEcCtD
Dinoprostone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00152	CcSEcCtD
Dinoprostone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000153	0.00152	CcSEcCtD
Dinoprostone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000153	0.00152	CcSEcCtD
Dinoprostone—Tremor—Metformin—type 2 diabetes mellitus	0.000152	0.00151	CcSEcCtD
Dinoprostone—Chest pain—Valsartan—type 2 diabetes mellitus	0.000152	0.00151	CcSEcCtD
Dinoprostone—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000152	0.00151	CcSEcCtD
Dinoprostone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000152	0.00151	CcSEcCtD
Dinoprostone—Dizziness—Glipizide—type 2 diabetes mellitus	0.000152	0.00151	CcSEcCtD
Dinoprostone—Tension—Irbesartan—type 2 diabetes mellitus	0.00015	0.0015	CcSEcCtD
Dinoprostone—Angiopathy—Losartan—type 2 diabetes mellitus	0.00015	0.0015	CcSEcCtD
Dinoprostone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00015	0.00149	CcSEcCtD
Dinoprostone—Chest pain—Orlistat—type 2 diabetes mellitus	0.00015	0.00149	CcSEcCtD
Dinoprostone—Myalgia—Orlistat—type 2 diabetes mellitus	0.00015	0.00149	CcSEcCtD
Dinoprostone—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000148	0.00147	CcSEcCtD
Dinoprostone—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000148	0.00147	CcSEcCtD
Dinoprostone—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000147	0.00147	CcSEcCtD
Dinoprostone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000146	0.00146	CcSEcCtD
Dinoprostone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000146	0.00145	CcSEcCtD
Dinoprostone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000146	0.00145	CcSEcCtD
Dinoprostone—Syncope—Metformin—type 2 diabetes mellitus	0.000146	0.00145	CcSEcCtD
Dinoprostone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000146	0.00145	CcSEcCtD
Dinoprostone—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000145	0.00144	CcSEcCtD
Dinoprostone—Rash—Glipizide—type 2 diabetes mellitus	0.000145	0.00144	CcSEcCtD
Dinoprostone—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000144	0.00144	CcSEcCtD
Dinoprostone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000144	0.00144	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000144	0.00144	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000144	0.00143	CcSEcCtD
Dinoprostone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000144	0.00143	CcSEcCtD
Dinoprostone—Headache—Glipizide—type 2 diabetes mellitus	0.000144	0.00143	CcSEcCtD
Dinoprostone—Tremor—Irbesartan—type 2 diabetes mellitus	0.000144	0.00143	CcSEcCtD
Dinoprostone—Shock—Valsartan—type 2 diabetes mellitus	0.000143	0.00142	CcSEcCtD
Dinoprostone—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000143	0.00142	CcSEcCtD
Dinoprostone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000142	0.00141	CcSEcCtD
Dinoprostone—Tension—Losartan—type 2 diabetes mellitus	0.000142	0.00141	CcSEcCtD
Dinoprostone—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000141	0.00141	CcSEcCtD
Dinoprostone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000141	0.0014	CcSEcCtD
Dinoprostone—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000141	0.0014	CcSEcCtD
Dinoprostone—Hypertension—Metformin—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Dinoprostone—Back pain—Losartan—type 2 diabetes mellitus	0.00014	0.00139	CcSEcCtD
Dinoprostone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000139	0.00139	CcSEcCtD
Dinoprostone—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000139	0.00138	CcSEcCtD
Dinoprostone—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000139	0.00138	CcSEcCtD
Dinoprostone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000138	0.00138	CcSEcCtD
Dinoprostone—Myalgia—Metformin—type 2 diabetes mellitus	0.000138	0.00138	CcSEcCtD
Dinoprostone—Chest pain—Metformin—type 2 diabetes mellitus	0.000138	0.00138	CcSEcCtD
Dinoprostone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000138	0.00137	CcSEcCtD
Dinoprostone—Syncope—Irbesartan—type 2 diabetes mellitus	0.000137	0.00137	CcSEcCtD
Dinoprostone—Nausea—Glipizide—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Dinoprostone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Dinoprostone—Hypotension—Valsartan—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Dinoprostone—Vision blurred—Losartan—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Dinoprostone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00135	CcSEcCtD
Dinoprostone—Pain—Gliclazide—type 2 diabetes mellitus	0.000135	0.00135	CcSEcCtD
Dinoprostone—Tremor—Losartan—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Dinoprostone—Rash—Glimepiride—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Dinoprostone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Dinoprostone—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000135	0.00134	CcSEcCtD
Dinoprostone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00134	CcSEcCtD
Dinoprostone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00134	CcSEcCtD
Dinoprostone—Headache—Glimepiride—type 2 diabetes mellitus	0.000134	0.00133	CcSEcCtD
Dinoprostone—Cough—Irbesartan—type 2 diabetes mellitus	0.000134	0.00133	CcSEcCtD
Dinoprostone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000134	0.00133	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000133	0.00132	CcSEcCtD
Dinoprostone—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000132	0.00132	CcSEcCtD
Dinoprostone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Dinoprostone—CYP1A2—liver—type 2 diabetes mellitus	0.000132	0.00289	CbGeAlD
Dinoprostone—Flushing—Ramipril—type 2 diabetes mellitus	0.000132	0.00131	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000131	0.0013	CcSEcCtD
Dinoprostone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000131	0.0013	CcSEcCtD
Dinoprostone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000131	0.0013	CcSEcCtD
Dinoprostone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000131	0.0013	CcSEcCtD
Dinoprostone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000131	0.0013	CcSEcCtD
Dinoprostone—Shock—Metformin—type 2 diabetes mellitus	0.00013	0.0013	CcSEcCtD
Dinoprostone—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Dinoprostone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00013	0.00129	CcSEcCtD
Dinoprostone—Syncope—Losartan—type 2 diabetes mellitus	0.000129	0.00129	CcSEcCtD
Dinoprostone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000129	0.00128	CcSEcCtD
Dinoprostone—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000128	0.00128	CcSEcCtD
Dinoprostone—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Dinoprostone—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000128	0.00127	CcSEcCtD
Dinoprostone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Dinoprostone—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Dinoprostone—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Dinoprostone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Dinoprostone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000127	0.00126	CcSEcCtD
Dinoprostone—Cough—Losartan—type 2 diabetes mellitus	0.000126	0.00125	CcSEcCtD
Dinoprostone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000125	0.00125	CcSEcCtD
Dinoprostone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000125	0.00125	CcSEcCtD
Dinoprostone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000125	0.00124	CcSEcCtD
Dinoprostone—Hypotension—Metformin—type 2 diabetes mellitus	0.000124	0.00123	CcSEcCtD
Dinoprostone—Shock—Irbesartan—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Pain—Orlistat—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Myalgia—Losartan—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Chest pain—Losartan—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000123	0.00122	CcSEcCtD
Dinoprostone—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Dinoprostone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Dinoprostone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000122	0.00121	CcSEcCtD
Dinoprostone—Tension—Ramipril—type 2 diabetes mellitus	0.000121	0.00121	CcSEcCtD
Dinoprostone—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Dinoprostone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Dinoprostone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000121	0.0012	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Dinoprostone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Dinoprostone—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000119	0.00118	CcSEcCtD
Dinoprostone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000118	0.00118	CcSEcCtD
Dinoprostone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000118	0.00117	CcSEcCtD
Dinoprostone—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Dinoprostone—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000117	0.00116	CcSEcCtD
Dinoprostone—Tremor—Ramipril—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Dinoprostone—Shock—Losartan—type 2 diabetes mellitus	0.000116	0.00115	CcSEcCtD
Dinoprostone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Dinoprostone—Tachycardia—Losartan—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Dinoprostone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000115	0.00114	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Dinoprostone—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Dinoprostone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Dinoprostone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Dinoprostone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000114	0.00113	CcSEcCtD
Dinoprostone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000112	0.00112	CcSEcCtD
Dinoprostone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000112	0.00112	CcSEcCtD
Dinoprostone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000112	0.00111	CcSEcCtD
Dinoprostone—Rash—Glyburide—type 2 diabetes mellitus	0.000111	0.00111	CcSEcCtD
Dinoprostone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000111	0.00111	CcSEcCtD
Dinoprostone—Syncope—Ramipril—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Dinoprostone—Headache—Glyburide—type 2 diabetes mellitus	0.000111	0.0011	CcSEcCtD
Dinoprostone—Hypotension—Losartan—type 2 diabetes mellitus	0.00011	0.00109	CcSEcCtD
Dinoprostone—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000109	0.00108	CcSEcCtD
Dinoprostone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000108	0.00108	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000108	0.00108	CcSEcCtD
Dinoprostone—Cough—Ramipril—type 2 diabetes mellitus	0.000108	0.00107	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000107	0.00107	CcSEcCtD
Dinoprostone—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000107	0.00107	CcSEcCtD
Dinoprostone—Pain—Irbesartan—type 2 diabetes mellitus	0.000107	0.00106	CcSEcCtD
Dinoprostone—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Dinoprostone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000106	0.00105	CcSEcCtD
Dinoprostone—Chest pain—Ramipril—type 2 diabetes mellitus	0.000105	0.00105	CcSEcCtD
Dinoprostone—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000105	0.00105	CcSEcCtD
Dinoprostone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000105	0.00105	CcSEcCtD
Dinoprostone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Dinoprostone—Nausea—Glyburide—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Dinoprostone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Dinoprostone—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000105	0.00104	CcSEcCtD
Dinoprostone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000104	0.00104	CcSEcCtD
Dinoprostone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000103	0.00103	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000102	0.00102	CcSEcCtD
Dinoprostone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000101	0.001	CcSEcCtD
Dinoprostone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000101	0.001	CcSEcCtD
Dinoprostone—Pain—Losartan—type 2 diabetes mellitus	0.000101	0.001	CcSEcCtD
Dinoprostone—Rash—Gliclazide—type 2 diabetes mellitus	9.99e-05	0.000993	CcSEcCtD
Dinoprostone—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.98e-05	0.000993	CcSEcCtD
Dinoprostone—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.96e-05	0.00099	CcSEcCtD
Dinoprostone—Shock—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000988	CcSEcCtD
Dinoprostone—Headache—Gliclazide—type 2 diabetes mellitus	9.93e-05	0.000987	CcSEcCtD
Dinoprostone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.89e-05	0.000983	CcSEcCtD
Dinoprostone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	9.89e-05	0.000983	CcSEcCtD
Dinoprostone—Tachycardia—Ramipril—type 2 diabetes mellitus	9.85e-05	0.00098	CcSEcCtD
Dinoprostone—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.84e-05	0.000979	CcSEcCtD
Dinoprostone—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	9.76e-05	0.00097	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	9.63e-05	0.000957	CcSEcCtD
Dinoprostone—Dizziness—Valsartan—type 2 diabetes mellitus	9.63e-05	0.000957	CcSEcCtD
Dinoprostone—Dizziness—Orlistat—type 2 diabetes mellitus	9.51e-05	0.000946	CcSEcCtD
Dinoprostone—Asthenia—Metformin—type 2 diabetes mellitus	9.51e-05	0.000946	CcSEcCtD
Dinoprostone—Hypotension—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000938	CcSEcCtD
Dinoprostone—Nausea—Gliclazide—type 2 diabetes mellitus	9.41e-05	0.000936	CcSEcCtD
Dinoprostone—Body temperature increased—Losartan—type 2 diabetes mellitus	9.31e-05	0.000926	CcSEcCtD
Dinoprostone—Abdominal pain—Losartan—type 2 diabetes mellitus	9.31e-05	0.000926	CcSEcCtD
Dinoprostone—Vomiting—Valsartan—type 2 diabetes mellitus	9.26e-05	0.00092	CcSEcCtD
Dinoprostone—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	9.22e-05	0.000917	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000915	CcSEcCtD
Dinoprostone—Rash—Valsartan—type 2 diabetes mellitus	9.18e-05	0.000913	CcSEcCtD
Dinoprostone—Dermatitis—Valsartan—type 2 diabetes mellitus	9.17e-05	0.000912	CcSEcCtD
Dinoprostone—Vomiting—Orlistat—type 2 diabetes mellitus	9.15e-05	0.000909	CcSEcCtD
Dinoprostone—Headache—Valsartan—type 2 diabetes mellitus	9.12e-05	0.000907	CcSEcCtD
Dinoprostone—Diarrhoea—Metformin—type 2 diabetes mellitus	9.07e-05	0.000902	CcSEcCtD
Dinoprostone—Rash—Orlistat—type 2 diabetes mellitus	9.07e-05	0.000902	CcSEcCtD
Dinoprostone—Paraesthesia—Ramipril—type 2 diabetes mellitus	9.06e-05	0.000901	CcSEcCtD
Dinoprostone—Dermatitis—Orlistat—type 2 diabetes mellitus	9.06e-05	0.000901	CcSEcCtD
Dinoprostone—Headache—Orlistat—type 2 diabetes mellitus	9.01e-05	0.000896	CcSEcCtD
Dinoprostone—Dyspnoea—Ramipril—type 2 diabetes mellitus	9e-05	0.000895	CcSEcCtD
Dinoprostone—Asthenia—Irbesartan—type 2 diabetes mellitus	8.98e-05	0.000893	CcSEcCtD
Dinoprostone—Dizziness—Metformin—type 2 diabetes mellitus	8.77e-05	0.000872	CcSEcCtD
Dinoprostone—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.67e-05	0.000863	CcSEcCtD
Dinoprostone—Nausea—Valsartan—type 2 diabetes mellitus	8.65e-05	0.00086	CcSEcCtD
Dinoprostone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.56e-05	0.000851	CcSEcCtD
Dinoprostone—Nausea—Orlistat—type 2 diabetes mellitus	8.54e-05	0.00085	CcSEcCtD
Dinoprostone—Asthenia—Losartan—type 2 diabetes mellitus	8.45e-05	0.00084	CcSEcCtD
Dinoprostone—Vomiting—Metformin—type 2 diabetes mellitus	8.43e-05	0.000838	CcSEcCtD
Dinoprostone—Rash—Metformin—type 2 diabetes mellitus	8.36e-05	0.000831	CcSEcCtD
Dinoprostone—Dermatitis—Metformin—type 2 diabetes mellitus	8.35e-05	0.00083	CcSEcCtD
Dinoprostone—Headache—Metformin—type 2 diabetes mellitus	8.3e-05	0.000826	CcSEcCtD
Dinoprostone—Dizziness—Irbesartan—type 2 diabetes mellitus	8.27e-05	0.000823	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	8.26e-05	0.000821	CcSEcCtD
Dinoprostone—Diarrhoea—Losartan—type 2 diabetes mellitus	8.06e-05	0.000801	CcSEcCtD
Dinoprostone—Abdominal pain—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000794	CcSEcCtD
Dinoprostone—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.98e-05	0.000794	CcSEcCtD
Dinoprostone—Vomiting—Irbesartan—type 2 diabetes mellitus	7.95e-05	0.000791	CcSEcCtD
Dinoprostone—Rash—Irbesartan—type 2 diabetes mellitus	7.89e-05	0.000784	CcSEcCtD
Dinoprostone—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.88e-05	0.000784	CcSEcCtD
Dinoprostone—Nausea—Metformin—type 2 diabetes mellitus	7.87e-05	0.000783	CcSEcCtD
Dinoprostone—Headache—Irbesartan—type 2 diabetes mellitus	7.84e-05	0.000779	CcSEcCtD
Dinoprostone—Dizziness—Losartan—type 2 diabetes mellitus	7.79e-05	0.000774	CcSEcCtD
Dinoprostone—Vomiting—Losartan—type 2 diabetes mellitus	7.49e-05	0.000744	CcSEcCtD
Dinoprostone—Hypersensitivity—Ramipril—type 2 diabetes mellitus	7.44e-05	0.00074	CcSEcCtD
Dinoprostone—Nausea—Irbesartan—type 2 diabetes mellitus	7.43e-05	0.000739	CcSEcCtD
Dinoprostone—Rash—Losartan—type 2 diabetes mellitus	7.42e-05	0.000738	CcSEcCtD
Dinoprostone—Dermatitis—Losartan—type 2 diabetes mellitus	7.42e-05	0.000737	CcSEcCtD
Dinoprostone—Headache—Losartan—type 2 diabetes mellitus	7.38e-05	0.000733	CcSEcCtD
Dinoprostone—Asthenia—Ramipril—type 2 diabetes mellitus	7.24e-05	0.00072	CcSEcCtD
Dinoprostone—Nausea—Losartan—type 2 diabetes mellitus	6.99e-05	0.000695	CcSEcCtD
Dinoprostone—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000687	CcSEcCtD
Dinoprostone—Dizziness—Ramipril—type 2 diabetes mellitus	6.68e-05	0.000664	CcSEcCtD
Dinoprostone—Vomiting—Ramipril—type 2 diabetes mellitus	6.42e-05	0.000638	CcSEcCtD
Dinoprostone—Rash—Ramipril—type 2 diabetes mellitus	6.37e-05	0.000633	CcSEcCtD
Dinoprostone—Dermatitis—Ramipril—type 2 diabetes mellitus	6.36e-05	0.000632	CcSEcCtD
Dinoprostone—Headache—Ramipril—type 2 diabetes mellitus	6.32e-05	0.000629	CcSEcCtD
Dinoprostone—Nausea—Ramipril—type 2 diabetes mellitus	6e-05	0.000596	CcSEcCtD
Dinoprostone—SLC22A1—Metabolism—CYP3A4—type 2 diabetes mellitus	2.84e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOB—type 2 diabetes mellitus	2.84e-06	2.3e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.82e-06	2.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GNB3—type 2 diabetes mellitus	2.82e-06	2.29e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.82e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.81e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—HMOX1—type 2 diabetes mellitus	2.81e-06	2.28e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.79e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—SLC2A4—type 2 diabetes mellitus	2.79e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GCG—type 2 diabetes mellitus	2.79e-06	2.27e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	2.79e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	2.79e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	2.79e-06	2.26e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CAT—type 2 diabetes mellitus	2.77e-06	2.24e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.76e-06	2.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.74e-06	2.23e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.74e-06	2.22e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—LPL—type 2 diabetes mellitus	2.71e-06	2.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.7e-06	2.19e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—type 2 diabetes mellitus	2.69e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOB—type 2 diabetes mellitus	2.69e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—RELA—type 2 diabetes mellitus	2.69e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.69e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTGS2—type 2 diabetes mellitus	2.68e-06	2.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	2.68e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	2.68e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.65e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.65e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—GPX1—type 2 diabetes mellitus	2.65e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—type 2 diabetes mellitus	2.61e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—type 2 diabetes mellitus	2.61e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SRC—type 2 diabetes mellitus	2.59e-06	2.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CD36—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	2.58e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—NOS3—type 2 diabetes mellitus	2.57e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.57e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.57e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AGT—type 2 diabetes mellitus	2.57e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—LPL—type 2 diabetes mellitus	2.57e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—type 2 diabetes mellitus	2.56e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.54e-06	2.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	2.54e-06	2.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	2.53e-06	2.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.53e-06	2.05e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.53e-06	2.05e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.52e-06	2.05e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOE—type 2 diabetes mellitus	2.51e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ADCY5—type 2 diabetes mellitus	2.51e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GPX1—type 2 diabetes mellitus	2.5e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.5e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	2.49e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	2.49e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	2.49e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.49e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.48e-06	2.01e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	2.46e-06	2e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.46e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.45e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.45e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.44e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CD36—type 2 diabetes mellitus	2.44e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.42e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.42e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.41e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.41e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.41e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.41e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	2.41e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.41e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	2.4e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARA—type 2 diabetes mellitus	2.4e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.36e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	2.36e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.35e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	2.35e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.34e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	2.34e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AGT—type 2 diabetes mellitus	2.32e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—type 2 diabetes mellitus	2.32e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.31e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—type 2 diabetes mellitus	2.31e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	2.31e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.3e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.3e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	2.29e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	2.29e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.29e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.29e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CALM1—type 2 diabetes mellitus	2.28e-06	1.85e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOE—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EGFR—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARA—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.27e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—APOA1—type 2 diabetes mellitus	2.25e-06	1.82e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	2.25e-06	1.82e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	2.23e-06	1.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	2.23e-06	1.81e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.22e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.22e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AGT—type 2 diabetes mellitus	2.19e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	2.19e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PPARG—type 2 diabetes mellitus	2.19e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	2.19e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	2.19e-06	1.77e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CALM1—type 2 diabetes mellitus	2.16e-06	1.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.16e-06	1.75e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOE—type 2 diabetes mellitus	2.15e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—INS—type 2 diabetes mellitus	2.15e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.15e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.14e-06	1.73e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—APOA1—type 2 diabetes mellitus	2.13e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.12e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	2.12e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	2.12e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	2.12e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	2.12e-06	1.72e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—type 2 diabetes mellitus	2.11e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.11e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.11e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.1e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	2.08e-06	1.69e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	2.08e-06	1.68e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.06e-06	1.67e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.06e-06	1.67e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.06e-06	1.67e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	2.03e-06	1.65e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	2.03e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	2.01e-06	1.63e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PPARG—type 2 diabetes mellitus	1.98e-06	1.61e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	1.98e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	1.97e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	1.97e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—type 2 diabetes mellitus	1.97e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.97e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	1.95e-06	1.58e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.94e-06	1.58e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.94e-06	1.58e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—INS—type 2 diabetes mellitus	1.94e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	1.94e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.93e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.93e-06	1.56e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.91e-06	1.55e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.89e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.89e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.89e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	1.89e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.88e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.88e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	1.87e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PPARG—type 2 diabetes mellitus	1.87e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.85e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.85e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	1.84e-06	1.5e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—INS—type 2 diabetes mellitus	1.84e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	1.84e-06	1.49e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	1.82e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.79e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—type 2 diabetes mellitus	1.78e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	1.76e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—type 2 diabetes mellitus	1.75e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	1.72e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	1.72e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.72e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.7e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—NOS3—type 2 diabetes mellitus	1.7e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	1.69e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—type 2 diabetes mellitus	1.68e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	1.68e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.68e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	1.68e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	1.68e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	1.68e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	1.67e-06	1.35e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	1.64e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	1.62e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.61e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NOS3—type 2 diabetes mellitus	1.61e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—type 2 diabetes mellitus	1.61e-06	1.31e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	1.6e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	1.57e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.56e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.51e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	1.51e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	1.51e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	1.51e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	1.48e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTGS2—type 2 diabetes mellitus	1.47e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	1.47e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.45e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	1.44e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.43e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—type 2 diabetes mellitus	1.42e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.42e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.38e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.38e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.38e-06	1.12e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.36e-06	1.11e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—type 2 diabetes mellitus	1.35e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.34e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.33e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.32e-06	1.07e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.31e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.31e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.31e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.31e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.26e-06	1.02e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	9.58e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.13e-06	9.13e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.13e-06	9.13e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.12e-06	9.09e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.11e-06	8.97e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.07e-06	8.71e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.04e-06	8.47e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.03e-06	8.32e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1e-06	8.14e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1e-06	8.11e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	9.74e-07	7.9e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	9.62e-07	7.8e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	9.23e-07	7.49e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	9.06e-07	7.35e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	8.77e-07	7.11e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—type 2 diabetes mellitus	8.66e-07	7.02e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	8.62e-07	7e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	8.59e-07	6.97e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	8.5e-07	6.89e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—type 2 diabetes mellitus	7.83e-07	6.35e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	7.49e-07	6.07e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—type 2 diabetes mellitus	7.41e-07	6.01e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	7.34e-07	5.96e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	6.79e-07	5.5e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	6.73e-07	5.46e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	6.44e-07	5.22e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	6.44e-07	5.22e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	6.33e-07	5.13e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	5.89e-07	4.78e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	2.96e-07	2.4e-06	CbGpPWpGaD
